Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2020 Financial Results on February 23, 2021

Inspire Medical Systems (NYSE: INSP) will announce its fourth quarter and full year 2020 financial results on February 23, 2021, following the market's close.

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) will announce its fourth quarter and full year 2020 financial results on February 23, 2021, following the market's close. A conference call is scheduled for 5:00 p.m. Eastern Time, where management will discuss these results and recent business developments. Inspire specializes in innovative solutions for obstructive sleep apnea, featuring the first FDA-approved neurostimulation technology, Inspire therapy, which offers an effective treatment option for moderate to severe cases.

Positive

• Inspire's proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology for obstructive sleep apnea.

Negative

• None.

Argus Session date unavailable

-0.78% session move Open Argus

Details

News Market Reaction – INSP

The recorded move for INSP in the trading session of this news was -0.78%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the fourth quarter and year ended December 31, 2020 after the close of trading on Tuesday, February 23.   Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Tuesday, February 23rd @ 5:00 p.m. Eastern Time:
Domestic:		877-407-0792
International:		201-689-8263
Conference ID:		13715465
Webcast:		http://public.viavid.com/index.php?id=143162

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Inspire Medical Systems release its financial results for Q4 2020?

Inspire Medical Systems will release its financial results for the fourth quarter and year ended December 31, 2020, on February 23, 2021.

What time is the Inspire Medical Systems conference call?

The conference call for Inspire Medical Systems will begin at 5:00 p.m. Eastern Time on February 23, 2021.

Where can I find more information about Inspire Medical Systems?

Additional information about Inspire Medical Systems can be found on their official website at www.inspiresleep.com.

What is Inspire Medical Systems known for?

Inspire Medical Systems is known for developing innovative and minimally invasive solutions for patients with obstructive sleep apnea.

What is Inspire therapy?

Inspire therapy is the first FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.